Clinical Trial Update: The Effect of Simvastatin Therapy on the Expression of Procoagulant and Inflammatory Markers in Heart Failure [EARLY_Phase 1]

View source ↗

Summary

A phase 1 trial evaluated the effect of simvastatin on procoagulant and inflammatory markers in patients with heart failure; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure

Drugs mentioned

• SIMVASTATIN (SIMVASTATIN)

Snippet

Sponsor: University of Utah | Conditions: Heart Failure | EARLY_Phase 1 | Status: COMPLETED